Functional Importance of Angiotensin-Converting Enzyme–Dependent In Situ Angiotensin II Generation in the Human Forearm
Authors:
- 1 March 2000
- journal article
- other
- Published by Wolters Kluwer Health in Hypertension
- Vol. 35 (3) , 764-768
Abstract
—To assess the importance for vasoconstriction of in situ angiotensin (Ang) II generation, as opposed to Ang II delivery via the circulation, we determined forearm vasoconstriction in response to Ang I (0.1 to 10 ng · kg−1· min−1) and Ang II (0.1 to 5 ng · kg−1· min−1) in 14 normotensive male volunteers (age 18 to 67 years). Changes in forearm blood flow (FBF) were registered with venous occlusion plethysmography. Arterial and venous blood samples were collected under steady-state conditions to quantify forearm fractional Ang I-to-II conversion. Ang I and II exerted the same maximal effect (mean±SEM 71±4% and 75±4% decrease in FBF, respectively), with similar potencies (mean EC50[range] 5.6 [0.30 to 12.0] nmol/L for Ang I and 3.6 [0.37 to 7.1] nmol/L for Ang II). Forearm fractional Ang I-to-II conversion was 36% (range 18% to 57%). The angiotensin-converting enzyme (ACE) inhibitor enalaprilat (80 ng · kg−1· min−1) inhibited the contractile effects of Ang I and reduced fractional conversion to 1% (0.1% to 8%), thereby excluding a role for Ang I-to-II converting enzymes other than ACE (eg, chymase). The Ang II type 1 receptor antagonist losartan (3 mg · kg−1· min−1) inhibited the vasoconstrictor effects of Ang II. In conclusion, the similar potencies of Ang I and II in the forearm, combined with the fact that only one third of arterially delivered Ang I is converted to Ang II, suggest that in situ–generated Ang II is more important for vasoconstriction than circulating Ang II. Local Ang II generation in the forearm depends on ACE exclusively and results in vasoconstriction via Ang II type 1 receptors.Keywords
This publication has 19 references indexed in Scilit:
- Distinction between surmountable and insurmountable selective AT1 receptor antagonists by use of CHO‐K1 cells expressing human angiotensin II AT1 receptorsBritish Journal of Pharmacology, 1999
- Dual pathway for angiotensin II formation in human internal mammary arteriesBritish Journal of Pharmacology, 1998
- Alternative pathways of angiotensin II production in the human saphenous veinBritish Journal of Pharmacology, 1998
- The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice.Journal of Clinical Investigation, 1997
- Angiotensin II formation in the intact human heart. Predominance of the angiotensin-converting enzyme pathway.Journal of Clinical Investigation, 1995
- Male–female differences in fertility and blood pressure in ACE-deficient miceNature, 1995
- Vasoconstrictor action of angiotensin I-convertase and the synthetic substrate (Pro11,D-Ala12)-angiotensin I.Hypertension, 1994
- Regional angiotensin II production in essential hypertension and renal artery stenosis.Hypertension, 1993
- A microcomputer-based, R-wave triggered system for hemodynamic measurements in the forearmComputers in Biology and Medicine, 1988
- Fate of Angiotensin I in the CirculationNature, 1968